Stock Market Crash: The past week (from 22 September to 26 September) was not good for the stock market. During this time, there was a strong decline in the Indian stock market. This decline was so big that Rs 16 lakh crore of investors drowned in just 5 days. On Friday alone, there was a loss of about 7 lakh crore rupees. On Friday, the Sensex broke down 733.22 points or 0.90 % to close at 80,426.46. With this, it recorded a decline of about 2,587 points in the last one week. At the same time, the Nifty 50 also fell 236.15 points or 0.95 percent to close at 24,654.70.

Why decline in the stock market?

• US President Donald Trump’s increase in fees for H-1B visa is under IT stock pressure. Due to this, the biggest decline in IT stocks was recorded. Because of this, the Nifty IT was the most declining sector on Friday. Shares of Indian IT companies like TCS, HCLTECH, Infosys recorded a decline in the sixth consecutive session on Friday. The Nifty IT index was 8 percent down. TCS has suffered the most. TCS 52- came to a lower level of week and since March 2020 it was the worst for TCS. The market cap has lost more than Rs 2 lakh crore due to a six -day decline in IT shares.
• Trump has also announced to impose 100 percent tariffs on the import of branded and patent medicines from 1 October. After this, many Indian pharma companies like Sun Pharma, Lupine, Aurobindo Pharma, Gland Pharma, Cipla declined by 10 percent on Friday. Fear is also that generic medicines will also be brought in the scope of tariffs, which are a large part of the portfolio of many of these pharma companies. The shares of small pharmaceutical companies like Walkhart, Caplin Point fell to 10 percent, while Sun Pharma shares came to a 52 -week low.
• Selling of foreign investors is also a major reason for this decline in the stock market. On Friday, foreign investors sold domestic shares worth 16,057.38 crore. At the same time, Indian investors also sold shares worth Rs 11,464.79 crore.
• The biggest contribution in the rise of 1,000 points in the index last week was that of the Nifty Bank. However, the Nifty got less support for the banking index. The Nifty Bank not only failed to maintain a level of 55,700, but also went down from the bottom 55,000 points and the support of 54,500 even below the zone, which increased the pressure on the Nifty.
• The fall in the rupee from Monday also had an impact on the stock market against the dollar. The rupee is weakening and trading around 88 against the dollar.
• The next week is going to be important for the market. The second quarter business updates will start coming from next week. From October 1, the sale of the auto sector will also come. Next week, RBI is also going to have a meeting of the Mudri Policy Committee, in which it is expected to get an update on the repo rate. The quarterly results will begin with the announcement of the TCS quarterly results on 9 October. The next week is also small because Thursday is a holiday.

Also read:

Return of 188 percent in 2 years … Now this Tata Group company announces stock spilt, know record date

Us pharma tariff: US President Donald Trump has ruled to impose 100 percent tariffs on import of drugs from India. On Thursday, Trump, while narrating his decree on Truth Social, Trump said that America will now put 100 percent tariffs on all branded and patent medicines coming here. This tariff will remain in force until manufacturing companies actively create their manufacturing unit in the US. That is, those companies will be excluded from the scope of tariff, whose plant has started to build in America or already has plants.

Relief to EU and Japan

According to a report by Bloomberg, it was later said by the White House that 100 percent pharma tariffs will not be imposed on European Union and Japan as they have been talking for a long time on the trade agreement. That is, even after the new order of Trump of 100 percent pharma tariff, the import of drugs on the European Union will be imposed only 15 percent. The same attitude will be adopted with Japan. The import of medicines and semiconductors from Japan will not take so much than other countries. Under trade deals, it has already been decided to impose 15 percent tariffs on import of drugs from Japan.

Why did Britain not survive?

Like India, Trump has instructed to impose 100 percent tariffs on medicines imported from Britain as well. It is being told that this new decree of Trump is part of his industrial and trade policy, under which he wants to reduce the dependence on the import of drugs in America and foreign companies start producing drugs in America.

In May, there was a trade agreement between the UK and the US, in which there was talk on the baseline tariff of 10 percent. However, negotiations on any fixed rate on import of drugs are still going on, so Britain has not received any discount from 100 percent pharma tariff for the present. Here, this order of Trump will be seen on the pharmaceutical industry of Britain. Pharma companies such as Astrazeneca and Glaxosmithkline can cause damage. Britain had exported drugs worth $ 6 billion to the US last year.

Also read:

300 meters excavation in the Andaman Sea, found of natural gas found; Watch video

Us pharma tariff: US President Donald Trump has announced to impose 100 percent tariffs on the import of branded and patent drugs since October 1, 2025. Issuing this new decree, Trump said that his aim is to promote the manufacture of domestic drugs in the US and also reduce America’s dependence on foreign imports.

America is one of the largest markets for Indian Forma companies. The two countries have a business of about $ 10 billion in the financial year 2025. Trump has created a stir in the Indian Forma market by adding 100 percent tariff to medicines, adding a new chapter to the tariff war. This will cause problems in export to Indian formma companies. Also, their market cap can also be reduced.

Shares of Forma companies broken

Since Trump’s new order, there has been a stir in the Forma sector of the Indian stock market. The shares of Cipla, Sun Forma and many big pharmaceutical companies are seeing a decline. In early trade, the Nifty Form index opened with a decline of 2.40 percent. Due to this, all 20 stocks were in loss, which has caused a lot of damage to the stock market.

According to Pharma and Healthcare expert Maitri Sheet of Choice Institutional Equites, 100 percent tariffs applied on branded and patent drugs can be challenging for Indian exporters. Indian exports have a 35 percent stake in the US market. Also, America is one of the largest markets for Indian Forma companies.

Which companies will not affect?

Maitri Sheet told that if a company has a factory in the US or has started construction, then in this situation they will be exempted from tariff. He has also told that only tariffs have been imposed on branded drugs, although it can also affect complex generic and important medicines.

Also read:

Trahimam in the Indian market with Trump’s tariff bomb, these shares scattered like cards